Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 17Terminated 4Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4NIH 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Lymphoid 1Breast 1

Conditions

Recurrence 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × tipifarnib × Clear all
NCT03496766 2025-03-05

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Spanish Lung Cancer Group

Phase 2 Terminated
9 enrolled 22 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00847223 2018-08-23

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Lymphoma Study Association

Phase 2 Terminated
11 enrolled
Lymphoid

Lymphoma, Recurrence, Lymphoma, Mantle-Cell

NCT00361088 2013-11-25

A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Terminated
42 enrolled
Plasma cell

Multiple Myeloma

NCT00210028 2006-11-14

Study Assessing Efficacy of ZARNESTRAâ„¢ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Institut Claudius Regaud

Phase 2 Terminated
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡